VON HIPPEL-LINDAU DISEASE

 

VON HIPPEL-LINDAU DISEASE

 

DEFINITION:

A neurocutaneous syndrome characterized by hemangioblastomas (cerebellar and retinal), visceral cysts, and tumors.

EPIDEMIOLOGY:

  • incidence: 1/36,000
  • age of onset:
    • any but usually in the 2nd decade
  • risk factors:
    • familial - autosomal dominant
      • chrom.#: 3p25-p26
      • gene: plasma membrane calcium-transporting ATPase isoform 2 (PMCA-2) gene
    • penetrance is almost complete by age 65 with delayed and variable expression even within the same kindred

PATHOGENESIS:

1. Genetic Defect

  • genetic defect -> mutation of PMCA-2 gene -> familial cancer syndrome that predisposes affected individuals to a variety of tumors:
    • hemangioblastomas of the central nervous system (CNS) and retina
    • renal cell carcinomas
    • pheochromocytomas
  • the PMCA-2 gene has been identified as a candidate for the VHL gene (Yao, M., Human Genetics 92:605-614 [1993])
  • congenital capillary hemangioblastomas are the basic lesion of VHL and involve the cerebellum and retina

PATHOLOGY:

1. Congenital Capillary Hemangioblastomas

1. Cerebellar Hemangioblastoma

  • tumors are usually well circumscribed and may be solid or cystic
  • microscopically, present as large numbers of thin-walled, closely packed blood vessels
  • usually found in the paramedial aspect and associated with prominent vessels but any cerebellar region affected

2. Retinal Hemangioblastoma (or angiomata)

  • characterized by small, raised masses of retinal tissue composed of thin-walled capillaries that are fed by large and tortuous arterioles and venules
  • may be divided into 3 categories
  • by ophthalmoscopic examination, may appear as a dilated artery leading from the disk to a peripheral tumor with an engorged vein
  • usually observed in the retinal periphery (so vision unaffected)

DIAGNOSTIC CRITERIA:

  • 1. more than 1 hemangioblastoma in the CNS
  • 2. 1 hemangioblastoma in the CNS + visceral cyst or renal carcinoma
  • 3. any manifestation with a family history
  • CLINICAL FEATURES:

    1. Neurological Manifestations

    1. CNS Hemangioblastomas

    • make up 2% of all brain tumors
    • make up 7-10% of all posterior fossae tumors

    2. Cerebellar Hemangioblastomas (83%)

    • mean age of onset is 32 yrs; before age 15 is rare
    • may present with posterior fossae signs/symptoms
      • obstructive hydrocephalus (with elevated intracranial pressure)
      • cerebellar signs (ataxia, nystagmus)
      • coning
    • associated with polycythemia in 10-50% of patients
    • all children presenting with cerebellar hemangioblastomas have VHL

    3. Other Sites

    1. Spinal Cord

    • 2nd most frequent site of CNS hemangioblastomas
    • present with abnormalities of proprioception, gait, and bladder dysfunction

    2. Others

    • Cerebral Hemispheres (20%), pituitary, medulla

    2. Ophthalmologic Manifestations

    1. Retinal Hemangioblastomas (46%)

    • may appear as early as the 1st decade but usually in 2nd (before the presentation of cerebellar hemangioblastomas)
    • may present:
      • vision unaffected (if tumor in periphery)
      • visual impairment with:
        • macular involvement
        • intraocular hemorrhage
        • retinal detachment secondary to exudation
      • may be multiple and bilateral
      • no sex predilection

    3. Others

    1. Visceral Cysts

    • tend to progress and become apparent during adult life
    • pancreatic (72%)
    • renal (59%)
    • hepatic (17%)
    • epididymis (7%)

    2. Other Tumors

  • 1. Pheochromocytomas (17%)
    • usually bilateral
    • limited to certain families where a pheochromocytoma is the first expression of VHL (may become manifest as early as 5 years of age)
    • may lead to subarachnoid hemorrhage in presence of a
    • CNS hemangioblastoma
  • 2. Renal Cell Carcinoma (51%)
    • malignant and most common cause of death in VHL
  • 3. Neurofibromatoses
  • 4. Multiple Endocrine Neoplasia Syndrome
  • Note: the clinical features vary widely from benign to devastating

    INVESTIGATIONS:

    1. Imaging Studies

  • 1. CT/MRI
    • cerebellar hemangioblastomas appear as cystic lesions with a vascular mural nodule
    • for visceral cysts and tumors
  • 2. Arteriography
    • to visualize blood supply to hemangioblastomas
  • 2. Serum

    • polycythemia (in 50% of patients with cerebellar hemangioblastomas)
    • hypercalcemia (with pheochromocytomas)

    3. CSF

    • elevated CSF protein with cerebellar hemangioblastomas

    4. Urine

    • VMA and HVA if suspect a pheochromocytoma

    MANAGEMENT:

    1. Surgery

  • 1. CNS Hemangioblastomas
    • total surgical removal is curative with evaculation of cystic structures and removal of mural nodules
    • recurrence is common with partial tumor resection
  • 2. Retinal Hemangioblastomas
    • laser therapy - photocoagulation and cryocoagulation
  • 2. Preventative

    • for children at risk, screen for:
      • retinal hemangioblastomas q5y
      • CNS hemangioblastomas q5y after age 15

    INTERNET LINKS:

    Von Hippel-Lindau Disease Family Alliance

     

    Pediatric Database - VON HIPPEL-LINDAU DISEASE

    Pediatric Organization - Pedbase [at] Gmail.com